RxDoctor Payments Data

Georgette Hodges

Family · Tyler, TXNPI 1487117578

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $681 and has fallen 98.3% since, to $12 in 2025.

$1,600in general payments, 2019–2025

Across 21 payments — averaging $76.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$269
  • Medtronic$249
  • Abbott$222
  • Axonics, Inc.$145
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$117
  • Teva Pharmaceuticals USA, Inc.$113
  • plus $486 from 7 others

What the payments were for

  • Food & beverage$1,59199%
  • Education$91%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,600 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Medicare billing

Part B allowed, 2024
$52,575
Medicare patients
258
Services billed
843

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin163$2,092
Pregabalin128$1,819
Methocarbamol106$1,220
Duloxetine Hcl43$939
Baclofen37$522
Tizanidine Hcl47$466
Amitriptyline Hcl21$447
Nortriptyline Hcl36$352
Acetaminophen-CodeineAcetaminophen With Codeine12$141
Methylprednisolone17$105
Piroxicam11$97
Tramadol Hcl11$61

Paid to pharmacies, not to this prescriber.

Other family in Tyler

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →